Platelet activation markers in children with congenital heart disease associated with pulmonary arterial hypertension

被引:18
作者
Mese, Timur [1 ]
Guven, Baris [2 ]
Yilmazer, Murat Muhtar [1 ]
Karadeniz, Cem [3 ]
Ozdemir, Rahmi [1 ]
Doksoz, Onder [1 ]
机构
[1] Univ Hlth Sci, Dept Pediat Cardiol, Dr Behcet Uz Childrens Hosp, Fac Med, Izmir, Turkey
[2] Univ Hlth Sci, Dept Pediat Cardiol, Izmir Tepecik Training Hosp, Fac Med, Izmir, Turkey
[3] Katip Celebi Univ, Div Pediat Cardiol, Fac Med, Izmir, Turkey
关键词
congenital heart disease; mean platelet volume; platelet activation; pulmonary hypertension; DISTRIBUTION WIDTH; VOLUME; SURVIVAL; THERAPY; INDEXES; REGISTRY;
D O I
10.1111/chd.12616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Mean platelet volume (MPV), platecrit, and platelet distribution width (PDW) are markers of platelet activation. Previous studies have found that platelet activation occurs in patients with pulmonary arterial hypertension. Platelet indices including MPV, PDW, and platecrit have not been studied in children with congenital heart disease associated pulmonary arterial hypertension (APAH-CHD) who survived and those who died. Objective: The objective of this study to investigate the value of platelet indices with clinical and hemodynamic indicators predicting the disease severity and survival in children with APAH-CHD. Methods: This was a nested case-control study. MPV, platecrit, and PDW levels measured in 37 patients with APAH-CHD and 43 healthy subjects at the beginning of the study. Right heart catheterization was performed in all 37 patients. Clinical and hemodynamic data were collected. All patients were followed from the date of laboratory testing. The study was conducted between March 2012-July 2015. The comparison of clinical, hemodynamic data and platelet indices were made between patients with APAH-CHD who died than APAH-CHD patients who survived. Results: Of 37 patients, after a mean follow-up duration of 67.90647.90 months, 11 patients died. MPV (12.10 femoliter [fL; 8.20-12.50] vs 8.70 fL [6.40-9.70], P5.007), PDW (16.88 +/- 1.09% vs 15.75 +/- 1.58%, P = .04) and platecrit (0.28 +/- 0.31 vs 0.22 +/- 0.27, P = .01) were significantly higher in the patients with APAH-CHD who died than those who survived. Pearson's correlation analysis showed that MPV correlated with mean pulmonary artery pressure (r = 0.332, P = .04) and correlated negatively with six-minute walking distance (r = -0.600. P = .00). PDW and platecrit correlated positively with mean pulmonary artery pressure (r = 0.373, P = .02; r = 0.389, P = .01, respectively). Conclusion: Our results showed that MPV, platecrit and PDW were increased in children with APAH-CHD. They might give clue about disease severity.
引用
收藏
页码:506 / 511
页数:6
相关论文
共 36 条
  • [1] Ansari MN, 2009, INDIAN J PHARM SCI, V71, P270, DOI 10.4103/0250-474X.56025
  • [2] Platelet Distribution Width and Mean Platelet Volume in Children With Pulmonary Arterial Hypertension Secondary to Congenital Heart Disease With Left-to-Right Shunt: New Indices of Severity?
    Arslan, Derya
    Cimen, Derya
    Guvenc, Osman
    Kaya, Fatma
    Sert, Ahmet
    Oran, Bulent
    [J]. PEDIATRIC CARDIOLOGY, 2013, 34 (04) : 1013 - 1016
  • [3] Evaluation of mean platelet volume (MPV) levels in patients with synovitis associated with knee osteoarthritis
    Balbaloglu, Ozlem
    Korkmaz, Murat
    Yolcu, Sadiye
    Karaaslan, Fatih
    Beceren, N. Gokben Cetin
    [J]. PLATELETS, 2014, 25 (02) : 81 - 85
  • [4] Vasodilator therapy for primary pulmonary hypertension in children
    Barst, RJ
    Maislin, G
    Fishman, AP
    [J]. CIRCULATION, 1999, 99 (09) : 1197 - 1208
  • [5] Platelet size: Measurement, physiology and vascular disease
    Bath, PMW
    Butterworth, RJ
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 (02) : 157 - 161
  • [6] Berger G, 2009, ISR MED ASSOC J, V11, P376
  • [7] Clinical features of paediatric pulmonary hypertension: a registry study
    Berger, Rolf M. F.
    Beghetti, Maurice
    Humpl, Tilman
    Raskob, Gary E.
    Ivy, D. Dunbar
    Jing, Zhi-Cheng
    Bonnet, Damien
    Schulze-Neick, Ingram
    Barst, Robyn J.
    [J]. LANCET, 2012, 379 (9815) : 537 - 546
  • [8] BURING J E, 1990, Journal of General Internal Medicine, V5, pS54, DOI 10.1007/BF02600843
  • [9] Enhanced hemostatic indices in patients with pulmonary arterial hypertension: An observational study
    Can, Mehmet Mustafa
    Tanboga, Ibrahim Halil
    Demircan, Hacer Ceren
    Ozkan, Alper
    Koca, Fatih
    Keles, Nursen
    Sonmez, Kenan
    Kaymaz, Cihangir
    Serebruany, Victor
    [J]. THROMBOSIS RESEARCH, 2010, 126 (04) : 280 - 282
  • [10] SURVIVAL IN PATIENTS WITH PRIMARY PULMONARY-HYPERTENSION - RESULTS FROM A NATIONAL PROSPECTIVE REGISTRY
    DALONZO, GE
    BARST, RJ
    AYRES, SM
    BERGOFSKY, EH
    BRUNDAGE, BH
    DETRE, KM
    FISHMAN, AP
    GOLDRING, RM
    GROVES, BM
    KERNIS, JT
    LEVY, PS
    PIETRA, GG
    REID, LM
    REEVES, JT
    RICH, S
    VREIM, CE
    WILLIAMS, GW
    WU, M
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (05) : 343 - 349